Nonalcoholic Steatohepatitis Treatment Market

Nonalcoholic steatohepatitis is a syndrome causes liver damage develops in the individuals who are not alcoholic. The primary mechanisms of nonalcoholic steatohepatitis are obesity, glucose intolerance, metabolic stress, inflammation, dyslipidemia and fibrosis. Nonalcoholic steatohepatitis can develop into cirrhosis and liver cancer. For the diagnosis of the nonalcoholic steatohepatitis, liver biopsy, imaging procedures and various types of blood tests including complete blood count, fasting blood sugar, liver enzyme tests etc. are required. The common nonalcoholic steatohepatitis treatment may include weight loss, type-2 diabetes treatment, a decrease of obesity etc. However, many drugs have been tested for the nonalcoholic steatohepatitis treatment only a few drugs such as vitamin E and pioglitazone showed a positive effect. Other drugs such as ursodeoxycholic acid, metformin, statins, orlistat and pentoxifylline showed only partially positive results.The major elements that can be considered for the pathological protagonists of nonalcoholic steatohepatitis are oxidative stress, altered lipid metabolism adipose and pancreas tissues, bile acids, gut microbiota, bacterial endotoxins, and systemic chronic inflammation.
Nonalcoholic Steatohepatitis Treatment Market contains market size and forecasts of Nonalcoholic Steatohepatitis Treatment in global, including the following market information:
Global Nonalcoholic Steatohepatitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nonalcoholic Steatohepatitis Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nonalcoholic Steatohepatitis Treatment companies in 2021 (%)
The global Nonalcoholic Steatohepatitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nonalcoholic Steatohepatitis Treatment include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals and Galectin Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nonalcoholic Steatohepatitis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nonalcoholic Steatohepatitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Type, 2021 (%)
Solid
Liquid
Global Nonalcoholic Steatohepatitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Diagnostic Center
Specialized Clinic
Hospital Pharmacy
Drug Store
Mail Order Pharmacy
Global Nonalcoholic Steatohepatitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nonalcoholic Steatohepatitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nonalcoholic Steatohepatitis Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nonalcoholic Steatohepatitis Treatment revenues share in global market, 2021 (%)
Key companies Nonalcoholic Steatohepatitis Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nonalcoholic Steatohepatitis Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead